BioMarin Pharmaceutical Inc. buy StockNews.com
Start price
29.04.23
/
50%
€88.08
Target price
29.04.24
-
Performance (%)
-13.03%
End price
30.04.24
€76.60
Summary
This prediction ended on 30.04.24 with a price of €76.60. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -13.03%. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BioMarin Pharmaceutical Inc. | 1.857% | 1.857% | -2.013% |
iShares Core DAX® | 1.280% | 1.027% | 11.234% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% |
Comments by StockNews_com for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten